Live Breaking News & Updates on Gensight Biologics Company Profile

Stay updated with breaking news from Gensight biologics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GenSight Biologics (OTCMKTS:GSGTF) Cut to "Neutral" at Chardan Capital

Chardan Capital downgraded shares of GenSight Biologics (OTCMKTS:GSGTF – Get Rating) from a buy rating to a neutral rating in a research note issued to investors on Thursday morning, The Fly reports. GenSight Biologics Stock Down 1.6 % Shares of GSGTF stock opened at $3.10 on Thursday. GenSight Biologics has a 12-month low of $3.10 […] ....

Connie Cepko , Botond Roska , Bernard Jacques Alex Gilly , Tjean Bennett , Gensight Biologics , Gensight Biologics Company Profile , Chardan Capital , Get Rating , Sight Biologics Stock Down , Gensight Biologics Daily , Otcmkts Gsgtf ,